Unique Differentiators

DNA-based vaccines offer distinct advantages for immunotherapy over other approaches such as peptide/RNA vaccines, or cell-based immunotherapies.

Immunetune’s key differentiators, implemented in NeoVAC, are:

  • Cost- and time-efficient GMP-compatible manufacturing of personalized DNA vaccins utilizing our rapid, scalable and cell-free production platform AmpliVax™
  • Fully synthetic linear construct design, which is in silico optimized using CADVax™ computerized technology
  • Optimized boosting of the elicited immune response by co-expressing our proprietary genetic adjuvant Pyrovant™